Biofrontera Inc. (BFRI): Price and Financial Metrics
BFRI Price/Volume Stats
| Current price | $1.10 | 52-week high | $2.43 |
| Prev. close | $1.07 | 52-week low | $0.61 |
| Day low | $1.05 | Volume | 179,200 |
| Day high | $1.10 | Avg. volume | 1,547,518 |
| 50-day MA | $0.99 | Dividend yield | N/A |
| 200-day MA | $1.15 | Market Cap | 8.52M |
BFRI Stock Price Chart Interactive Chart >
Biofrontera Inc. (BFRI) Company Bio
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
BFRI Price Returns
| 1-mo | 12.42% |
| 3-mo | 15.44% |
| 6-mo | 5.77% |
| 1-year | -32.93% |
| 3-year | -98.41% |
| 5-year | N/A |
| YTD | 0.92% |
| 2024 | -60.65% |
| 2023 | -84.89% |
| 2022 | -87.81% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...